Abstract
The invention provides myo-inositol deratives substituted with two or more phosphorothioate groups and selected from myo-inositol-1,3-bisphosphorothioate; myo-inositol-1,4-bisphosphorothioate; myo-inositol-1,5-bisphosphorothioate; myo-inositol-1,4,5-trisphosphorothioate; and myo-inositol-1,3,4,5-tetrakisphosphorothioate.
Original language | English |
---|---|
Patent number | EP0579957A1 |
IPC | C07F9/177 |
Priority date | 2/07/87 |
Filing date | 4/07/88 |
Publication status | Published - 26 Jan 1994 |